Details about Paolo Pertile

Access statistics for papers by Paolo Pertile.

Last updated 2023-10-22. Update your information in the RePEc Author Service.

Short-id: ppe336

Working Papers

2023

1. Dynamic, incentive-compatible contracting for health services
   FEEM Working Papers, Fondazione Eni Enrico Mattei (FEEM)
   Also in Working Papers, Fondazione Eni Enrico Mattei (2023)

2022

2. Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany
   Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York

2019

3. R&D and market size: who benefits from orphan drug regulation?
   Working Papers, University of Verona, Department of Economics View citations (1)

2018

4. Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence
   Discussion Papers, Department of Economics, University of York View citations (2)

2016

5. Pricing policies when patients are heterogeneous: a welfare analysis
   Working Papers, University of Verona, Department of Economics View citations (2)

2015

6. A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response
   Discussion Papers, Department of Economics, University of York View citations (1)
   See also Journal Article A Bayesian decision theoretic model of sequential experimentation with delayed response, Journal of the Royal Statistical Society Series B, Royal Statistical Society (2017) View citations (9) (2017)
7. Late-Stage Pharmaceutical R & D and Pricing Policies under Two-Stage Regulation
   Discussion Papers, Department of Economics, University of York View citations (1)
   See also Journal Article Late-stage pharmaceutical R&D and pricing policies under two-stage regulation, Journal of Health Economics, Elsevier (2016) View citations (10) (2016)
8. Public policies over the life cycle: a large scale OLG model for France, Italy and Sweden
   Working Papers, University of Verona, Department of Economics View citations (2)
9. Who should monitor job sick leave?
   Working Papers, University of Verona, Department of Economics View citations (1)

2014

10. L’ISEE in Italia: Una Nota Metodologica Partendo dai Dati IT-SILC
    Working Papers, University of Verona, Department of Economics View citations (4)

2013

11. Redistribution at the Local Level: The Case of Public Childcare in Italy
    Working Papers, University of Verona, Department of Economics View citations (3)
    See also Journal Article Redistribution at the local level: the case of public childcare in Italy, International Review of Economics, Springer (2016) View citations (2) (2016)
12. The dynamics of pharmaceutical regulation and R&D investments
    Working Papers, University of Verona, Department of Economics View citations (4)
    See also Journal Article The Dynamics of Pharmaceutical Regulation and R&D Investments, Journal of Public Economic Theory, Association for Public Economic Theory (2017) View citations (7) (2017)

2012

13. DRGs: the link between investment in technologies and appropriateness
    Working Papers, University of Verona, Department of Economics View citations (1)
14. Modelling life-course decisions for the analysis of interpersonal and intrapersonal redistribution
    Working Papers, University of Verona, Department of Economics
15. Public finance consolidation and fairness across living generations: the case of Italy
    Working Papers, University of Verona, Department of Economics

2011

16. Dynamic, economic approaches to HTA under uncertainty
    Working Papers, University of Verona, Department of Economics

2010

17. Optimal sequential sampling rules for the economic evaluation of health technologies
    Discussion Papers, Department of Economics, University of York View citations (4)
18. Static and Dynamic Efficiency of Irreversible Health Care Investments under Alternative Payment Rules
    Working Papers, Fondazione Eni Enrico Mattei View citations (6)
    See also Journal Article Static and dynamic efficiency of irreversible health care investments under alternative payment rules, Journal of Health Economics, Elsevier (2012) View citations (17) (2012)

Journal Articles

2021

1. A reply to “Who would benefit from average value‐based pricing?”
   Health Economics, 2021, 30, (9), 2284-2286
2. R&D and market size: Who benefits from orphan drug legislation?
   Journal of Health Economics, 2021, 80, (C) View citations (3)

2020

3. Authors’ Reply to Garattini and Freemantle: “Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition”
   Applied Health Economics and Health Policy, 2020, 18, (3), 455-456
4. The impact of managed entry agreements on pharmaceutical prices
   Health Economics, 2020, 29, (S1), 47-62 View citations (3)
5. Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition
   Applied Health Economics and Health Policy, 2020, 18, (3), 357-362 View citations (4)
6. Which valued‐based price when patients are heterogeneous?
   Health Economics, 2020, 29, (8), 923-935 View citations (5)

2019

7. Job sick leave: Detecting opportunistic behavior
   Health Economics, 2019, 28, (3), 373-386

2017

8. A Bayesian decision theoretic model of sequential experimentation with delayed response
   Journal of the Royal Statistical Society Series B, 2017, 79, (5), 1439-1462 View citations (9)
   See also Working Paper A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response, Discussion Papers (2015) View citations (1) (2015)
9. A large scale OLG model for the analysis of the redistributive effects of policy reforms
   European Journal of Political Economy, 2017, 48, (C), 104-127 View citations (19)
10. The Dynamics of Pharmaceutical Regulation and R&D Investments
    Journal of Public Economic Theory, 2017, 19, (1), 121-141 View citations (7)
    See also Working Paper The dynamics of pharmaceutical regulation and R&D investments, Working Papers (2013) View citations (4) (2013)

2016

11. Late-stage pharmaceutical R&D and pricing policies under two-stage regulation
    Journal of Health Economics, 2016, 50, (C), 298-311 View citations (10)
    See also Working Paper Late-Stage Pharmaceutical R & D and Pricing Policies under Two-Stage Regulation, Discussion Papers (2015) View citations (1) (2015)
12. Redistribution at the local level: the case of public childcare in Italy
    International Review of Economics, 2016, 63, (4), 359-378 View citations (2)
    See also Working Paper Redistribution at the Local Level: The Case of Public Childcare in Italy, Working Papers (2013) View citations (3) (2013)

2015

13. The fiscal disadvantage of young Italians: a new view on consolidation and fairness
    The Journal of Economic Inequality, 2015, 13, (1), 27-51 View citations (1)

2014

14. Optimal Bayesian sequential sampling rules for the economic evaluation of health technologies
    Journal of the Royal Statistical Society Series A, 2014, 177, (2), 419-438 View citations (10)
15. Two-part payments for the reimbursement of investments in health technologies
    Health Policy, 2014, 115, (2), 230-236 View citations (10)

2013

16. Optimal decision rules for HTA under uncertainty: a wider, dynamic perspective
    Health Economics, 2013, 22, (12), 1507-1514 View citations (4)

2012

17. Static and dynamic efficiency of irreversible health care investments under alternative payment rules
    Journal of Health Economics, 2012, 31, (1), 169-179 View citations (17)
    See also Working Paper Static and Dynamic Efficiency of Irreversible Health Care Investments under Alternative Payment Rules, Working Papers (2010) View citations (6) (2010)

2009

18. An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography
    International Journal of Health Economics and Management, 2009, 9, (3), 317-332 View citations (3)
19. The timing of adoption of positron emission tomography: a real options approach
    Health Care Management Science, 2009, 12, (3), 217-227 View citations (2)

2008

20. Investment in Health Technologies in a Competitive Model with Real Options
    Journal of Public Economic Theory, 2008, 10, (5), 923-952 View citations (5)

2006

21. Technology adoption, quality and health care costs: a review of the literature
    STUDI ECONOMICI, 2006, 2006/90, (90), 81-107 View citations (1)